Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities.
In this study, we aimed to estimate the contribution of environmental pollutants to the incidence, prevalence, mortality, and costs of pediatric disease in American children. We examined four categories of illness: lead poisoning, asthma, cancer, and neurobehavioral disorders. To estimate the proportion of each attributable to toxins in the environment, we used an environmentally attributable fraction (EAF) model. EAFs for lead poisoning, asthma, and cancer were developed by panels of experts through a Delphi process, whereas that for neurobehavioral disorders was based on data from the National Academy of Sciences. We define environmental pollutants as toxic chemicals of human origin in air, food, water, and communities. To develop estimates of costs, we relied on data from the U.S. Environmental Protection Agency, Centers for Disease Control and Prevention, National Center for Health Statistics, the Bureau of Labor Statistics, the Health Care Financing Agency, and the Practice Management Information Corporation. EAFs were judged to be 100% for lead poisoning, 30% for asthma (range, 10-35%), 5% for cancer (range, 2-10%), and 10% for neurobehavioral disorders (range, 5-20%). Total annual costs are estimated to be $54.9 billion (range $48.8-64.8 billion): $43.4 billion for lead poisoning, $2.0 billion for asthma, $0.3 billion for childhood cancer, and $9.2 billion for neurobehavioral disorders. This sum amounts to 2.8 percent of total U.S. health care costs. This estimate is likely low because it considers only four categories of illness, incorporates conservative assumptions, ignores costs of pain and suffering, and does not include late complications for which etiologic associations are poorly quantified. The costs of pediatric environmental disease are high, in contrast with the limited resources directed to research, tracking, and prevention.
Landrigan
Philip J
PJ
The Center for Children's Health and the Environment and The Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. phil.landrigan@mssm.edu
Schechter
Clyde B
CB
Lipton
Jeffrey M
JM
Fahs
Marianne C
MC
Schwartz
Joel
J
D001249:Asthma / Q000191:economics / Q000209:etiology*; D002669:Child Welfare; D002675:Child, Preschool; D002658:Developmental Disabilities / Q000191:economics / Q000209:etiology*; D004781:Environmental Exposure; D004782:Environmental Health; D004785:Environmental Pollutants / Q000009:adverse effects*; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D007855:Lead Poisoning / Q000191:economics / Q000209:etiology*; D008297:Male; D008962:Models, Theoretical; D009017:Morbidity / Q000639:trends; D009026:Mortality / Q000639:trends; D009369:Neoplasms / Q000191:economics / Q000209:etiology*; D010372:Pediatrics; D015995:Prevalence
D004785:Environmental Pollutants